For General Information: (740) 374-1400

24 Hour Nurse Line: (844) 474-6522

Filter by Custom Post Type
About Us
Careers
Community
Locations
Memorial Health Foundation
News
Pages
Patient and Visitors
Providers
Services

X


Angiotensin II receptor blockers

November, 15th, 2023


Benefit Summary


Overview

, , ,

Angiotensin 2 receptor blockers are a type of medicine used to treat high blood pressure. This type of medicine also may be called angiotensin II receptor blockers.

Angiotensin is a chemical in the body that narrows the blood vessels. When blood vessels are narrow, blood pressure can go up.

Angiotensin 2 receptor blockers stop the action of angiotensin 2. As a result, the medicine helps relax the veins and arteries in the body, lowering blood pressure.

Several angiotensin 2 receptor blockers are available. Which one is best for you depends on your health and the condition being treated.

Examples of angiotensin 2 receptor blockers include:

  • Azilsartan (Edarbi).
  • Candesartan (Atacand).
  • Irbesartan (Avapro).
  • Losartan (Cozaar).
  • Olmesartan (Benicar).
  • Telmisartan (Micardis).
  • Valsartan (Diovan).

When these medicines are used

In addition to treating high blood pressure, angiotensin 2 receptor blockers may prevent, treat or improve symptoms in people who have:

  • Chronic kidney disease.
  • Heart failure.
  • Kidney failure due to diabetes.

Side effects

Possible side effects of angiotensin 2 receptor blockers can include:

  • Dizziness.
  • Too much potassium in the blood.
  • Swelling of the skin due to extra fluid.

Some people taking the angiotensin 2 receptor blocker olmesartan (Benicar) have reported digestive problems. Talk to your health care team if you have severe diarrhea or lose a lot of weight while taking this medicine.

Don’t take angiotensin 2 receptor blockers if you’re pregnant or you plan to become pregnant. The medicines can harm a developing baby while growing in the womb.

Talk to your health care team if you have any questions about the medicines you take.